May 15, 2025 / 12:00PM GMT
Operator
Dear ladies and gentlemen, welcome to the Merck investor and analyst conference call on first quarter 2025. (Operator Instructions)
I am now handing over to Florian Schraeder, Head of Investor Relations, who will lead you through this conference. Please go ahead, sir.
Florian Schraeder - Merck KGaA - Head of Investor Relations
Thank you so much, Heidi. And a very warm welcome to this Merck Q1 '25 results call. My name is Florian Schraeder. I'm the Head of Investor Relations here at Merck.
I'm delighted to be joined today by Belén Garijo, our Group CEO; as well as Helene von Roeder, our Group CFO. For the Q&A part of this call, we will also have Matthias Heinzel, CEO, Life Science; Jean-Charles Wirth, Designated CEO, Life Science; Peter Guenter, CEO, Healthcare; Danny Bar-Zohar, Designated CEO, Healthcare; as well as Kai Beckmann, CEO, Electronics.
In the first couple of minutes of this call, we would like to guide you through the key slides of the presentation. After that, we will be more than happy to take your questions.
Q1 2025 Merck KGaA Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
